A new protein, MORC3,that regulates nuclear localization of proteins, and MORC protein family
调节蛋白质核定位的新蛋白MORC3以及MORC蛋白家族
基本信息
- 批准号:16590237
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In oncogenic signals, transcriptional regulation, telomere maintenance and cellular senescence, proteins are regulated by recruitment into nuclear subdomains. We show that MORC3 is involved in the conditional or constitutive localization of proteins in PML-body. Sp100 is localized in PML-NBs in MORC3-expressing cells but dispersed into entire nuclei in ATPase-deficient MORC3 mutant (E35A) expressing cells and in MORC3-repressed cells by shRNA expression. The tumor suppressor p53 is recruited into PML-NBs by oncogenic signal. Overexpression of MORC3 mediated p53 recruitment into PML-NBs. MORC3 but not MORC3-E35A enhanced p53-transcriptional activation in luciferase reporter gene analyses for p53-responsive elements, or the promoters of p21 or Bax. In addition, MORC3 induced endogenous p21 expression. Furthermore, we generated Morc3-targeted mice. All Morc3-/- mice died at birth or within a day. Morc3+/+, +/- and -/- embryos at 18.5 days postcoitum (dpc) were present at almost the expected Mendelian ratio. We generated mouse embryonic fibroblasts (MEFs) from Morc3+/+ and -/- embryos at 14.5 dpc. In Morc3-/- MEFs, p53 was stabilized through posttranslational modification including phosphorylation at serine 18 and 23 but barely activated by the treatment of adriamycin.Morc3-/- mice showed abnormal development of myeloid lineage and small thymus. In vitro CFU assay by Morc3-/- fetal liver, GM-CSF but not M-CSF mediated development to monocyte.New nomenclature for MORC family proteins (MORC1,MORC2,MORC3 and MORC4 in human and Morc1,Morc2a, Morc2b, Morc3 and Morc4 in mouse) were proposed by us and accepted in HUGO and MGD.
在致癌信号、转录调节、端粒维持和细胞衰老中,蛋白质通过募集到核亚结构域中来调节。我们表明,MORC 3是参与在PML体的蛋白质的条件性或组成性定位。Sp100定位于M0 RC 3表达细胞中的PML-NB中,但在ATP酶缺陷型M0 RC 3突变体(E35 A)表达细胞中和通过shRNA表达的M0 RC 3抑制细胞中分散到整个细胞核中。肿瘤抑制基因p53通过致癌信号被募集到PML-NB中。M0 RC 3的过表达介导p53募集到PML-NB中。在荧光素酶报告基因分析中,MORC 3而不是MORC 3-E35 A增强了p53-转录激活,用于p53-响应元件或p21或Bax的启动子。此外,MORC 3诱导内源性p21表达。此外,我们产生了Morc 3靶向小鼠。所有Morc 3-/-小鼠在出生时或在一天内死亡。Morc 3 +/+、+/-和-/-胚胎在交配后18.5天(dpc)几乎以预期的孟德尔比率存在。我们在14.5 dpc从Morc 3 +/+和-/-胚胎产生小鼠胚胎成纤维细胞(MEF)。在Morc 3-/- MEFs中,p53通过翻译后修饰(包括丝氨酸18和23位的磷酸化)得以稳定,但阿霉素几乎不能激活p53; Morc 3-/-小鼠表现出异常的髓系发育和小胸腺。MORC家族蛋白的新命名(人MORC 1、MORC 2、MORC 3和MORC 4,小鼠MORC 1、MORC 2a、MORC 2b、MORC 3和MORC 4)已被HUGO和MGD所接受。
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular basis of clonal expansion of hematopoiesis in two patients with paroxysmal nocturnal hemoglobinuria (PNH)
两例阵发性睡眠性血红蛋白尿症 (PNH) 患者造血克隆扩张的分子基础
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Inoue;N.;et al.
- 通讯作者:et al.
Regulator of Complement Activation (RCA) Locus in Chicken : Identification of Chicken RCA Gene Cluster and Functional RCA Proteins.
鸡补体激活 (RCA) 基因座的调节因子:鸡 RCA 基因簇和功能性 RCA 蛋白的鉴定。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Oshiumi;H
- 通讯作者:H
NF-B-Activating Kinase-Associated Protein 1 Participates in TLR3/Toll-IL-1 Homology Domain-Containing Adapter Molecule-1-Mediated IFN Regulatory Factor 3 Activation
NF-B 激活激酶相关蛋白 1 参与含有接头分子 1 的 TLR3/Toll-IL-1 同源结构域介导的 IFN 调节因子 3 激活
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ito;T.et al.;Miwa Sasai
- 通讯作者:Miwa Sasai
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INOUE Norimitsu其他文献
Complement-related thrombosis
补体相关血栓形成
- DOI:
10.2491/jjsth.32.695 - 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
MIYATA Toshiyuki;INOUE Norimitsu - 通讯作者:
INOUE Norimitsu
INOUE Norimitsu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INOUE Norimitsu', 18)}}的其他基金
Development of anticancer immunoadjuvant therapy against glycolysis
针对糖酵解的抗癌免疫辅助疗法的开发
- 批准号:
24501336 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulatory mechanism of PML body function by MORC3
MORC3对PML机体功能的调节机制
- 批准号:
21590326 - 财政年份:2009
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional in vivo and in vitro analysis of MORC3, which regulates nuclear domain
MORC3(调节核结构域)的功能体内和体外分析
- 批准号:
18590281 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Mechanisms for the clonal expansion of abnormal cells in hematopoietic stem cell disorders
造血干细胞疾病中异常细胞克隆扩增的分子机制
- 批准号:
14370313 - 财政年份:2002
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)